SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 110.74 |
| Enterprise Value ($M) | 33.72 |
| Book Value ($M) | 170.68 |
| Book Value / Share | 5.56 |
| Price / Book | 0.65 |
| NCAV ($M) | 153.10 |
| NCAV / Share | 4.99 |
| Price / NCAV | 0.72 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.22 |
| Return on Assets (ROA) | -0.39 |
| Return on Equity (ROE) | -0.41 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 38.41 |
| Current Ratio | 38.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 157.19 |
| Assets | 174.78 |
| Liabilities | 4.09 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Blue Owl Capital Holdings LP | 4.32 | -20.91 | |
| 13G/A | Point72 Asset Management, L.P. | 8.00 | 53.05 | |
| 13G/A | Baker Bros. Advisors Lp | 4.99 | 5.63 | |
| 13G/A | Hillhouse Capital Management, Ltd. | 2.40 | -50.00 | |
| 13G/A | Fmr Llc | 2.44 | -61.38 | |
| 13G | Kpcb Pandemic & Bio Defense Fund Llc | 6.30 | ||
| 13G | New Enterprise Associates 13 Lp | 6.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 77,453 | 391,088 | 19.80 | |
| 46,752 | 440,824 | 10.61 | |
| 110,948 | 560,654 | 19.79 | |
| 97,313 | 603,227 | 16.13 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RYTM – Rhythm Pharmaceuticals, Inc. | SAGE – Sage Therapeutics, Inc. |
| SCYX – SCYNEXIS, Inc. | SIGA – SIGA Technologies, Inc. |
| SKYE – Skye Bioscience, Inc. |
Financial data and stock pages provided by
Fintel.io